Quality of Life Through Reducing Medication-Related Lifestyle Burden Across Care Transitions

Abstract

Medication-related lifestyle burden is a significant yet underappreciated determinant of quality of life, particularly during transitions of care. This review critically examines the epidemiology, pathophysiology, risk factors, and clinical features of medication-related lifestyle burden, emphasizing its impact on patient outcomes. Evidence-based strategies for mitigating this burden, including streamlined regimens, patient engagement, and multidisciplinary approaches, are discussed with reference to current guideline recommendations and emerging innovations, aiming to inform clinicians and support the delivery of patient-centered care across care transitions.

Introduction

Transitions of care, such as hospital discharge or transfer between care settings, are critical junctures that often involve complex medication regimens. These changes may inadvertently increase medication-related lifestyle burden, adversely impacting adherence, satisfaction, and ultimately, quality of life. Healthcare professionals must recognize and address this burden to optimize therapeutic outcomes and minimize preventable harm. This article synthesizes current evidence and clinical guidance to support informed, patient-centered interventions targeting medication-related lifestyle burden during care transitions.

Epidemiology / Disease Burden

Medication-related burden encompasses the practical, psychological, and social challenges patients experience in managing complex medication regimens. Epidemiological data indicate that polypharmacy and regimen complexity are prevalent among older adults, patients with multimorbidity, and those transitioning between care settings. Studies show that up to 60% of elderly patients are discharged on five or more medications, with 20-30% experiencing medication-related problems post-discharge. This burden is associated with increased hospital readmissions, reduced adherence, impaired daily functioning, and diminished quality of life. The magnitude of the issue underscores the necessity for systematic interventions to reduce lifestyle disruption and optimize care transitions.

Pathophysiology

The pathophysiology of medication-related lifestyle burden is multifactorial. Frequent dosing, dietary restrictions, adverse effects, and drug-drug interactions disrupt routines and can cause cumulative psychological stress. These disruptions often lead to cognitive overload, health anxiety, and reduced self-efficacy. Physiologically, the burden may manifest as fatigue, sleep disturbances, or gastrointestinal symptoms, further complicating disease management. Mechanistically, the interplay between medication effects, comorbidities, and lifestyle factors necessitates an individualized approach to minimize harm and maximize therapeutic benefit.

Risk Factors

Risk factors for increased medication-related lifestyle burden include advanced age, cognitive impairment, polypharmacy, low health literacy, and limited social support. Transitions of care, particularly from hospital to home or between providers, are high-risk periods due to changes in medication regimens, potential communication gaps, and variable patient engagement. Socioeconomic status, language barriers, and comorbidity profiles also modulate risk, highlighting the need for tailored interventions and culturally competent care strategies.

Clinical Features

Clinically, patients experiencing medication-related lifestyle burden may report difficulties adhering to medication schedules, inability to integrate treatment into daily routines, and emotional distress related to side effects or regimen complexity. Features such as missed doses, unintentional nonadherence, decreased motivation, social withdrawal, and decreased participation in self-care activities are common. Healthcare providers should proactively assess for these features using validated tools such as the Medication Regimen Complexity Index (MRCI) and medication-related burden questionnaires.

Diagnosis

Diagnosis of medication-related lifestyle burden requires a comprehensive, patient-centered assessment. This involves detailed medication reconciliation, review of dosing schedules, and exploration of patient-reported challenges. Structured interviews and standardized instruments such as the Living with Medicines Questionnaire (LMQ) and Adherence to Refills and Medications Scale (ARMS) can facilitate identification of burden and guide targeted interventions. Early recognition is crucial to mitigate negative outcomes and support effective care transitions.

Treatment & Management

Management strategies center on reducing regimen complexity, enhancing patient education, and fostering shared decision-making. Deprescribing unnecessary medications, consolidating dosing schedules, and utilizing fixed-dose combinations are practical approaches. Multidisciplinary care teams including pharmacists, nurses, and case managers play a pivotal role in medication review, patient counseling, and care coordination. Digital health tools and medication adherence technologies can further support self-management, particularly during vulnerable transitions. Tailoring interventions to individual needs and preferences remains a cornerstone of effective burden reduction.

Recent Advances / Emerging Therapies

Recent advances in medication management include the integration of electronic health records (EHRs) for seamless medication reconciliation, artificial intelligence-driven risk stratification for high-burden patients, and the development of patient-centered mobile applications to track adherence and report adverse events. Emerging therapies focus on long-acting formulations, once-daily dosing, and targeted deprescribing protocols. Multimodal interventions that combine behavioral support, telemedicine, and remote monitoring are demonstrating promise in improving adherence and reducing medication-related lifestyle burden across care transitions.

Guideline Recommendations

Current clinical guidelines from organizations such as the American Geriatrics Society, National Institute for Health and Care Excellence (NICE), and the World Health Organization emphasize individualized medication review, deprescribing when appropriate, and patient engagement as best practices during care transitions. These guidelines advocate for regular assessment of medication appropriateness, routine monitoring for adverse effects, and clear communication across multidisciplinary teams. Implementing guideline-based protocols has been shown to decrease medication burden, enhance patient satisfaction, and improve overall quality of life.

Conclusion

Reducing medication-related lifestyle burden is imperative for enhancing patient quality of life, particularly during transitions of care. Clinicians must employ evidence-based, patient-centered strategies to streamline medication regimens, engage patients in shared decision-making, and leverage technological advances to support adherence and continuity of care. Ongoing research, multidisciplinary collaboration, and guideline-driven practice will remain essential in addressing this complex challenge and promoting optimal health outcomes across the care continuum.